Back
Construction Partners Vs. Novo Nordisk AS Industry Stock Comparison
Sell
47
ROAD
Construction Partners
Last Price:
$92.73
Seasonality Move:
6.43%
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$84.75
Seasonality Move:
6.94%
Sell
47
Construction Partners (ROAD)
is a Sell
Is Construction Partners a Buy, Sell or Hold?
-
The current Construction Partners [ROAD] share price is $92.87. The Score for ROAD is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ROAD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ROAD Stock Price Chart
What is Construction Partners's stock price today?
-
The Construction Partners share price today is $92.87The current trend is moderately bearish and ROAD is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $84.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ROAD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.67 | Buy |
Relative Strength Index (14 RSI): | 47.83 | Sell |
Chaikin Money Flow: | 427389 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.45 - 100.65) | Sell |
Bollinger Bands (100): | (62.17 - 91.47) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.51 | Sell |
Relative Strength Index (14 RSI): | 24.55 | Sell |
Chaikin Money Flow: | 64911 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.57 - 111.43) | Sell |
Bollinger Bands (100): | (107.18 - 131.16) | Sell |
ROAD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.18 | Sell |
20-day SMA: | 97.7 | Sell |
50-day SMA: | 89.37 | Buy |
200-day SMA: | 66.16 | Buy |
8-day EMA: | 93.96 | Sell |
20-day EMA: | 94.83 | Sell |
50-day EMA: | 89.26 | Buy |
200-day EMA: | 69.39 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.03 | Sell |
20-day SMA: | 106.85 | Sell |
50-day SMA: | 109.33 | Sell |
200-day SMA: | 126.14 | Sell |
8-day EMA: | 102.09 | Sell |
20-day EMA: | 105.65 | Sell |
50-day EMA: | 110.06 | Sell |
200-day EMA: | 118.01 | Sell |
Construction Partners Earnings Growth & ROAD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $0.64 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Construction Partners Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |